The Monkeypox (Mpox) Diagnosis Market is driven by
increasing awareness and concerns regarding orthopoxvirus infections

The Monkeypox (Mpox) Diagnosis Market involves the diagnosis
of Monkeypox disease through tests and kits. The disease is caused by the
Monkeypox virus which is part of the Orthopoxvirus genus. Monkeypox can spread
to humans through close contact with an infected person or animal, or with
material contaminated with the virus. The virus enters the body through broken
skin, respiratory tract, or the mucous membranes (eyes, nose, or mouth). Once
inside the body, it uses the immune cells as vehicles and travels through the
lymph system to other organs. Common symptoms include fever, headache, muscle
aches, backache, swollen lymph nodes, chills, and exhaustion. Rashes or sores
may appear on the face, inside the mouth, and other parts of the body,
especially the hands, feet, chest, genitals, or anus.



The global Monkeypox
(Mpox) Diagnosis Market Demand is driven by increasing awareness about
orthopoxvirus infections like Monkeypox. The sudden rise in cases across
multiple non-endemic countries has led to more screening programs being
implemented worldwide. Diagnostic technologies play a key role in confirming
suspected cases and controlling the spread of the disease.

Global monkeypox (Mpox) diagnosis market is estimated to be
valued at USD 1.97 Bn in 2024 and is expected to reach USD
2.62 Bn by 2031, exhibiting a compound annual growth rate (CAGR)
of 4.2% from 2024 to 2031.



Key Takeaways

Key players operating in the Monkeypox (Mpox) Diagnosis market are Aegis
Sciences Corporation, Laboratory Corporation of America Holdings, Quest
Diagnostics Incorporated, Sonic Healthcare Limited, QIAGEN, Mayo Clinic
Laboratories, Chembio Diagnostics, Inc., Sonora Quest Laboratories, Thermo
Fisher Scientific, BD (Becton, Dickinson and Company), CerTest Biotech, GenMark
Diagnostics, Inc., Roche Diagnostics, Abbott Laboratories, Hologic, Inc.,
Siemens Healthineers, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Agilent
Technologies, Inc., and Meridian Bioscience, Inc.

Get More
Insights on-
Monkeypox
(Mpox) Diagnosis Market